Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 8, 2025 • 9:00 PM ET

Date/Time Source News Release
05/27/2025 07:30 AM EDT GlobeNewswire Adagene to Present at Jefferies Global Healthcare Conference 2025
05/22/2025 05:05 PM EDT GlobeNewswire Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting
04/28/2025 08:00 AM EDT GlobeNewswire Adagene Appoints John Maraganore, Ph.D. as Executive Advisor
04/23/2025 10:05 AM EDT GlobeNewswire Adagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual Meeting
04/07/2025 08:00 AM EDT GlobeNewswire Adagene to Present at Stifel's 2025 Virtual Targeted Oncology Forum
03/24/2025 08:00 AM EDT GlobeNewswire Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update
03/13/2025 08:00 AM EDT GlobeNewswire Adagene to Present at 11th Annual Immuno-Oncology 360? Summit
03/06/2025 08:00 AM EST GlobeNewswire Adagene to Present at Leerink's Global Healthcare Conference 2025
02/27/2025 08:00 AM EST GlobeNewswire Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer
01/27/2025 07:00 AM EST GlobeNewswire Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium
Page
  • 1
  • 2

Additional News

As of June 8, 2025 • 9:00 PM ET

Date/Time Source News Release
06/03/2025 09:40 AM EDT Zacks Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
05/09/2025 04:52 PM EDT SeekingAlpha Adagene announces $200M mixed shelf offering
04/04/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Friday, April 4th, 2025
04/04/2025 05:30 AM EDT US Earnings Reports Expected earnings - Adagene Inc.
03/24/2025 12:11 PM EDT SeekingAlpha Adagene ADR Non-GAAP EPS of -$0.51 beats by $0.07, revenue of $0.1M misses by $9.4M
01/08/2025 09:40 AM EST Zacks Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
12/23/2024 09:40 AM EST Zacks Is Bioventus (BVS) Outperforming Other Medical Stocks This Year?
12/06/2024 09:40 AM EST Zacks Are Medical Stocks Lagging Adagene (ADAG) This Year?
11/20/2024 09:40 AM EST Zacks Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
Page
  • 1

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.